María Fernanda
López Fernández
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (17)
2022
-
Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency
Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1369-1378
2021
-
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
Blood Cells, Molecules, and Diseases, Vol. 86
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports
-
Expanding the genetic spectrum of TUBB1-related thrombocytopenia
Blood Advances, Vol. 5, Núm. 24, pp. 5453-5467
2020
2019
-
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
Scientific Reports, Vol. 9, Núm. 1
-
Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency
Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418
-
Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients
Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 127-132
-
Management of adult patients with primary immune thrombocytopenia (itp) in clinical practice: A consensus approach of the Spanish itp expert group
Advances in Hematology, Vol. 2019
2018
-
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders
Haematologica, Vol. 103, Núm. 1, pp. 148-162
2010
-
Pharmacogenetics of acenocoumarol in patients with extreme dose requirements
Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 5, pp. 1012-1017
1988
-
Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy
American Journal of Hematology, Vol. 27, Núm. 4, pp. 291-298
1986
-
The heterogeneity of Type IIA von Willebrand's disease: Studies with protease inhibitors
Blood, Vol. 68, Núm. 6, pp. 1207-1212
-
Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy
Scandinavian Journal of Haematology, Vol. 36, Núm. 3, pp. 302-308
1985
-
RESPUESTA AL DDAVP EN LA ENFERMEDAD DE VON WILLEBRAND TIPO II C
Sangre, Vol. 30, Núm. 2, pp. 181-184
1984
-
PERSPECTIVA ACTUAL DE LA ENFERMEDAD DE VON WILLEBRAND
Anales de Medicina Interna, Vol. 1, Núm. 2, pp. 39-47
1981
-
COMPLEMENTO Y EDEMA ANGIONEUROTICO HEREDITARIO. MECANISMO DE SUS INTERRELACIONES E INFLUENCIA DEL DANAZOL
Medicina Clinica, Vol. 77, Núm. 9, pp. 380-385